DaVita Inc.
$183.86
$0.77 (+0.42%)
$181.27Day Range$185.84
Key Statistics
Market Cap
$11.73B
Shares Outstanding
63.8M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Oct 31, 1995
Round Lot
100
Locale
US
Trading Data
Day Open
$183.96
Day High
$185.84
Day Low
$181.27
Volume
2.10M
VWAP
$183.71
Prev Close
$183.09
Transactions
--
Acc. Volume
--
About DaVita Inc.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
SERVICES-MISC HEALTH & ALLIED SERVICES, NECSIC 809078,000 employees2000 16TH STREET, DENVER, CO, 80202310-536-2668IPO Oct 31, 1995US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000927066
- Composite FIGI
- BBG000MQ1SN9
- Share Class FIGI
- BBG001SB5DZ0
- Ticker Root
- DVA
- SIC Code
- 8090
About DaVita Inc. (DVA) Stock
DaVita Inc. (DVA) closed the 2026-09-18 session at $183.86, up 0.42% versus the previous close (+0.77). The stock opened at $183.96 and traded between $181.27 and $185.84 during that session. Session trading volume was 2.1M shares. The volume-weighted average price (VWAP) is $183.71.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
DaVita Inc. has a market capitalization of $11.73 billion. The company operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry classification. DVA is listed on the XNYS exchange. The company employs approximately 78,000 people. DaVita Inc. is headquartered in DENVER, CO. The recorded listing date is 1995-10-31.
On this page you can find market DVA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector.